Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F17/00—Metallocenes
  • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines
  • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P33/00—Antiparasitic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P33/00—Antiparasitic agents
  • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
  • A61P33/06—Antimalarials
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
  • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
  • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D215/38—Nitrogen atoms
  • C07D215/42—Nitrogen atoms attached in position 4
  • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
  • C07F15/02—Iron compounds

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• General Health & Medical Sciences (AREA)
• Tropical Medicine & Parasitology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Epidemiology (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Quinoline Compounds (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=42752115

Family Applications (1)

Country Status (26)

Families Citing this family (7)

Citations (1)

Family Cites Families (7)

• 2010
  • 2010-06-11 FR FR1054625A patent/FR2961209B1/fr active Active
• 2011
  • 2011-06-09 JO JO2011190A patent/JO2928B1/en active
  • 2011-06-09 AR ARP110101985A patent/AR081593A1/es unknown
  • 2011-06-10 MA MA35540A patent/MA34363B1/fr unknown
  • 2011-06-10 PH PH1/2012/502453A patent/PH12012502453A1/en unknown
  • 2011-06-10 NZ NZ605608A patent/NZ605608A/en not_active IP Right Cessation
  • 2011-06-10 JP JP2013513804A patent/JP5916721B2/ja active Active
  • 2011-06-10 EP EP11729738.2A patent/EP2580224B1/en active Active
  • 2011-06-10 WO PCT/IB2011/052536 patent/WO2011154923A1/en not_active Ceased
  • 2011-06-10 PY PY201101123645A patent/PY1123645A/es unknown
  • 2011-06-10 CA CA2802161A patent/CA2802161C/en active Active
  • 2011-06-10 TW TW100120422A patent/TWI485136B/zh not_active IP Right Cessation
  • 2011-06-10 AP AP2012006595A patent/AP3020A/xx active
  • 2011-06-10 SG SG2012090502A patent/SG186247A1/en unknown
  • 2011-06-10 CN CN201180028786.2A patent/CN102939297B/zh active Active
  • 2011-06-10 EA EA201291209A patent/EA020392B1/ru not_active IP Right Cessation
  • 2011-06-10 BR BR112012031159A patent/BR112012031159A2/pt not_active Application Discontinuation
  • 2011-06-10 KR KR1020127032234A patent/KR101839634B1/ko not_active Expired - Fee Related
  • 2011-06-10 MX MX2012014473A patent/MX2012014473A/es active IP Right Grant
  • 2011-06-10 AU AU2011263354A patent/AU2011263354B2/en not_active Ceased
  • 2011-06-10 UY UY0001033447A patent/UY33447A/es not_active Application Discontinuation
• 2012
  • 2012-12-07 CL CL2012003455A patent/CL2012003455A1/es unknown
  • 2012-12-09 IL IL223521A patent/IL223521A/en active IP Right Grant
  • 2012-12-10 ZA ZA2012/09328A patent/ZA201209328B/en unknown
  • 2012-12-10 US US13/709,710 patent/US8497375B2/en active Active
  • 2012-12-11 CO CO12223884A patent/CO6602116A2/es not_active Application Discontinuation
• 2016
  • 2016-02-10 JP JP2016023254A patent/JP2016145214A/ja active Pending

Patent Citations (1)

Also Published As

Similar Documents